Skip to main content

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) Investor Investigation Concerning Potential Securities Laws Violations Announced

  • Investors who purchased shares of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), have certain options. Please contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Investigation Overview

An investigation on behalf of investors of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) shares over potential securities laws violations by Regeneron Pharmaceuticals, Inc. and certain of its directors and officers in connection with certain financial statements was announced. The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Rege...



You must register (for free) or login to view the entire investigation.